Over the past year, Alphabet Inc. has gone from an artificial intelligence afterthought to the one firm in the market with ...

Do you want to know the best way to invest in the next big thing? Looking at what the so-called "smart money" is doing is a ...

A striking observation from Charles Schwab’s On Investing podcast episode “Concentration Risk Meets Diversification Reality” ...

ABC announced a fall schedule on Tuesday that doesn't look much different than last year's, but with one major exception: ...

The Trump-era rally is alive, well, and could bring markets to more elevated heights as we move through the summer months. Undoubtedly, not everyone is bullish on stocks at fresh highs, especially ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

Google ⁠parent Alphabet is planning its first multi-tranche yen-denominated bond ‌sale, according to a term sheet seen by ...

Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising ...

Residents of a historic London street are protesting against Google's self-driving car unit, Waymo, after its vehicles ...

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.

The pilot will initially be available only for orders placed via the Wing app.

This partnership, which will operate in parts of Charlotte, is the first between the Alphabet-backed Wing and a national QSR ...